Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostatic Neoplasms
- Sponsor
- Copenhagen University Hospital at Herlev
- Enrollment
- 178
- Locations
- 1
- Primary Endpoint
- Preferred treatment/control frequency for patients with advanced prostate cancer
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval.
Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A diagnosis of advanced prostate cancer
- •Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)
Exclusion Criteria
- •Inability to read/write Danish
Outcomes
Primary Outcomes
Preferred treatment/control frequency for patients with advanced prostate cancer
Time Frame: Up to 1 year
Preferred treatment frequency is assessed by patient answers to the question: "If treatments were equally effective from a medical standpoint - How often would you then prefer to receive treatment"
Secondary Outcomes
- Treatment satisfaction(Up to 1 year)
- Side effects to treatment(Up to 1 year)
- Treatment satisfaction, preferred frequency of clinical control, and side effects after surgical castration(Up to 1 year)